Short-read Sequencing Market Size Was Valued at USD 6.32 Billion in 2023, and is Projected to Reach USD 24.7 Billion by 2032, Growing at a CAGR of 18.6% From 2024-2032.

Short-read Sequencing (NGS), another call for brief-read sequencing, is a robust and famous technique for deciphering DNA sequences. Millions of tiny DNA fragments, commonly ranging in length from 50 to three hundred base pairs, are rapidly sequenced as a part of this system. This approach has furnished high-throughput, accurate, and low priced sequencing records, revolutionizing the sector of genomic studies. In order to carry out brief-study sequencing, the DNA sample is damaged up into tiny bits, adaptors are introduced, and polymerase chain response (PCR) is used to enlarge the fragments. After that, the amplified fragments are sequenced concurrently, resulting within the rapid manufacturing of considerable volumes of information. Illumina and Ion Torrent are  essential technologies for brief-read sequencing; they hire distinct chemistries however produce comparable effects. The Numerous applications, such as entire-genome sequencing, targeted sequencing, RNA sequencing, and epigenetic studies, depend upon this technology. Large-scale projects like populace genetics, disorder studies, and customized remedy can advantage from its excessive accuracy and scalability. However, because of the low read duration, brief-study sequencing might also have trouble with repetitive areas and structural variations.

Get Free Sample Request Report Here: https://introspectivemarketresearch.com/request/12182

What is short read sequencing used for?

Epigenetic Studies: Short-read sequencing is used to analyze DNA methylation patterns and histone modifications, providing insights into gene regulation and epigenetic changes related to development and disease.

Microbiome Analysis: Sequencing microbial DNA from environmental samples or the human microbiome allows for the identification and characterization of microbial communities, their diversity, and their roles in health and disease.

RNA Sequencing (RNA-Seq): Used to study gene expression profiles, RNA-Seq helps in understanding transcriptional activity, identifying novel transcripts, and detecting differential gene expression in different conditions or tissues.

Top Key Players

·         Illumina, Inc. (San Diego, California, USA)

·         Thermo Fisher Scientific, Inc. (Waltham, Massachusetts, USA)

·         Pacific Biosciences of California, Inc. (Menlo Park, California, USA)

·         BGI (Shenzhen, Guangdong, China)

·         QIAGEN (Hilden, Germany)

·         Agilent Technologies (Santa Clara, California, USA)

·         Psomagen (Rockville, Maryland, USA)

·         Azenta US, Inc. (GENEWIZ) (South Plainfield, New Jersey, USA)

·         PerkinElmer, Inc. (Waltham, Massachusetts, USA)

·         ProPhase Labs, Inc. (Nebula Genomics) (Ambler, Pennsylvania, USA), and Other Key Players

Short-read Sequencing Market Drivers:

·         Technological Advancements: Continuous improvements in sequencing technologies enhance accuracy, speed, and cost-effectiveness, making short-read sequencing more accessible and reliable.

·         Decreasing Costs: The cost of sequencing has dramatically decreased, enabling widespread adoption in research, clinical diagnostics, and personalized medicine.

·         Growing Demand for Precision Medicine: Short-read sequencing plays a crucial role in precision medicine by identifying genetic variations and mutations, leading to personalized treatment plans and better patient outcomes.

·         High Throughput: The ability to sequence millions of DNA fragments simultaneously accelerates research and clinical applications, allowing for large-scale genomic studies and quick data generation.

Short-read Sequencing Market Opportunities:

·         Expansion in Clinical Diagnostics: Short-read sequencing is increasingly used for diagnosing genetic disorders, guiding personalized therapies, and monitoring disease progression, presenting significant growth opportunities in clinical settings.

·         Emerging Markets: Developing regions with improving healthcare infrastructure and increasing investment in genomics research offer substantial market expansion potential.

·         Integration with AI and Bioinformatics: Combining short-read sequencing with advanced bioinformatics and artificial intelligence can enhance data analysis, interpretation, and the discovery of novel genetic insights.

·         Collaborative Research Initiatives: Partnerships between academic institutions, healthcare providers, and biotech companies can drive innovation and expand the applications of short-read sequencing.

If You Have Any Query of Needle Biopsy Market Report, Visit: https://introspectivemarketresearch.com/inquiry/12182

Segmentation Analysis of the Needle Biopsy Market:

By Product

·         Instruments

·         Consumables

·         Services

By Workflow

·         Pre-Sequencing

·         Sequencing

·         Data Analysis

By Application

·         Whole Genome Sequencing

·         Whole Exome Sequencing

·         Targeted Sequencing & Resequencing

·         DNA-based

·         RNA-based

·         Others

By End-User

·         Academic & Research Institutes

·         Hospitals & Clinics

·         Pharmaceutical & Biotechnology Companies

·         Others

Get Free Sample Request Report Here: https://introspectivemarketresearch.com/request/12182

By Region

·         North America (U.S., Canada, Mexico)

·         Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)

·         Western Europe (Germany, U.K., France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)

·         Asia-Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)

·         Middle East & Africa (Turkey, Saudi Arabia, Bahrain, Kuwait, Qatar, UAE, Israel, South Africa)

·         South America (Brazil, Argentina, Rest of SA)

Company Profiles and Competitive Analysis:

  1. COMPETITIVE LANDSCAPE
  2. Competitive Positioning
  3. Industrial Lighting Market Share By Manufacturer (2022)
  4. Industry BCG Matrix
  5. Heat Map Analysis
  6. Mergers & Acquisitions
  7. ARIEL CORPORATION
  8. Company Overview
  9. Key Executives
  10. Company Snapshot
  11. Role of the Company in the Market
  12. Sustainability and Social Responsibility
  13. Operating Business Segments
  14. Product Portfolio
  15. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
  16. Key Strategic Moves and Recent Developments
  17. SWOT Analysis

Acquire this Market Research Report Now: https://introspectivemarketresearch.com/checkout/?user=1&_sid=12182

About Us:

Introspective Market Research Private Limited (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assisting our clients to grow and have a successful impact on the market. Our team at IMR is ready to assist our clients to flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, that specializes in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Get in Touch with Us:

Canada Office

Introspective Market Research Private Limited, 138 Downes Street Unit 6203- M5E 0E4, Toronto, Canada.

Introspective Market Research Private Limited

APAC Office: Office No. 401, Saudamini Commercial Complex, Kothrud, Pune, India 411038

Email: sales@introspectivemarketresearch.com

LinkedIn | Twitter | Facebook